Cardinal Health (BSP:C1AH34) Cyclically Adjusted Revenue per Share: R$3,942.80 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSP:C1AH34 Cardinal Health Inc BSP:C1AH34
71 GF Score
Price R$1,175.30
GF Value R$701.86
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Cardinal Health Cyclically Adjusted Revenue per Share?

Cardinal Health BSP:C1AH34 +1.95% 71 Cyclically Adjusted Revenue per Share is R$3,942.80 as of Mar. 2026. GuruFocus rates BSP:C1AH34 with a GF Score™ of 71/100 and a GF Value™ of R$701.86 (Significantly Overvalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Cardinal Health's adjusted revenue per share for the three months ended in Mar. 2026 was R$1,350.389. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is R$3,942.80 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Cardinal Health's average Cyclically Adjusted Revenue Growth Rate was 11.70% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 11.70% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 12.50% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 9.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Cardinal Health was 17.00% per year. The lowest was 4.90% per year. And the median was 12.00% per year.

As of today (2026-08-03), Cardinal Health's current stock price is R$1175.30. Cardinal Health's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was R$3,942.80. Cardinal Health's Cyclically Adjusted PS Ratio of today is 0.30.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Cardinal Health was 0.31. The lowest was 0.11. And the median was 0.16.


Cardinal Health  (BSP:C1AH34) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Cardinal Health's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=1175.30/3942.80
=0.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Cardinal Health was 0.31. The lowest was 0.11. And the median was 0.16.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Cardinal Health Cyclically Adjusted Revenue per Share Related Terms


Cardinal Health Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Cardinal Health's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cardinal Health Cyclically Adjusted Revenue per Share Chart

Cardinal Health Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,183.35 2,530.40 2,462.04 3,659.00 3,487.36

Cardinal Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,598.36 3,487.36 3,741.82 4,135.96 3,942.80

BSP:C1AH34 vs COR, HSIC, MCK: Cyclically Adjusted Revenue per Share Comparison

For the Medical Distribution subindustry, Cardinal Health's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cardinal Health Cyclically Adjusted PS Ratio vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Cardinal Health's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Cardinal Health's Cyclically Adjusted PS Ratio falls into.


BSP:C1AH34
71GF Score
Cardinal Health Inc BSP:C1AH34
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cardinal Health Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Cardinal Health's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=1350.389/330.2130*330.2130
=1,350.389

Current CPI (Mar. 2026) = 330.2130.

Cardinal Health Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 328.563 241.018 450.156
201609 323.693 241.428 442.731
201612 348.543 241.432 476.712
201703 312.957 243.801 423.880
201706 339.488 244.955 457.649
201709 321.534 246.819 430.172
201712 366.892 246.524 491.443
201803 350.104 249.554 463.262
201806 427.247 251.989 559.876
201809 472.809 252.439 618.477
201812 488.532 251.233 642.112
201903 452.509 254.202 587.817
201906 483.295 256.143 623.052
201909 519.683 256.759 668.355
201912 554.736 256.974 712.839
202003 650.779 258.115 832.558
202006 649.683 257.797 832.181
202009 719.969 260.280 913.413
202012 724.461 260.474 918.427
202103 752.784 264.877 938.470
202106 728.380 271.696 885.256
202109 803.139 274.310 966.815
202112 914.786 278.802 1,083.472
202203 811.352 287.504 931.879
202206 870.220 296.311 969.785
202209 952.741 296.808 1,059.970
202212 1,034.389 296.797 1,150.850
202303 1,019.250 301.836 1,115.074
202306 1,012.831 305.109 1,096.166
202309 1,083.936 307.789 1,162.906
202312 1,144.123 306.746 1,231.652
202403 1,115.231 312.332 1,179.078
202406 1,305.464 314.175 1,372.105
202409 1,181.631 315.301 1,237.516
202412 1,387.513 315.605 1,451.735
202503 1,311.174 319.799 1,353.871
202506 1,395.941 322.561 1,429.056
202509 1,436.319 324.800 1,460.256
202512 1,510.722 324.054 1,539.435
202603 1,350.389 330.213 1,350.389

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of R$3,942.80 mean?
Cardinal Health (BSP:C1AH34) has a Cyclically Adjusted Revenue per Share of R$3,942.80 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Cardinal Health and its competitors.
Is Cardinal Health's Cyclically Adjusted Revenue per Share too high?
Cardinal Health's current Cyclically Adjusted Revenue per Share is R$3,942.80. Overall, Cardinal Health has a GF Score™ of 71/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cardinal Health's Cyclically Adjusted Revenue per Share compare to COR and HSIC?
Cardinal Health's Cyclically Adjusted Revenue per Share of R$3,942.80 can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Distribution company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Distribution industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Cardinal Health and its competitors. Cardinal Health's current Cyclically Adjusted Revenue per Share is R$3,942.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cardinal Health stock overvalued right now?
Based on GuruFocus' analysis, Cardinal Health (BSP:C1AH34) is currently considered Significantly Overvalued. The stock's GF Value™ is R$701.86, compared to a current price of R$1,175.30 — trading 67.5% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is R$3,942.80. Cardinal Health's overall GF Score™ is 71/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Cardinal Health (BSP:C1AH34), the current Cyclically Adjusted Revenue per Share is R$3,942.80 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cardinal Health (BSP:C1AH34) Overvalued in 2026?

Based on GuruFocus' analysis, Cardinal Health stock appears to be overvalued. The current stock price of R$1,175.30 is trading 67.5% above its estimated GF Value™ of R$701.86. GuruFocus considers Cardinal Health to be Significantly Overvalued.

Key valuation signals for BSP:C1AH34:

  • Cyclically Adjusted Revenue per Share: R$3,942.80
  • GF Value™: R$701.86 vs. price of R$1,175.30 (67.5% above fair value)
  • GF Score™: 71/100 with 6 warning signs

No single metric tells the full story. See the BSP:C1AH34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Cardinal Health Business Description

Address 7000 Cardinal Place, Dublin, OH, USA, 43017
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
71GF Score

Get the complete analysis for BSP:C1AH34

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$1,175.30
Price
R$701.86
GF Value